Guidant
This article was originally published in The Gray Sheet
Executive Summary
Firm files premarket approval application with FDA Feb. 28 for its Contak CD pulse generator and Easytrak lead for congestive heart failure. The Contak, which combines cardiac resynchronization capability with implantable defibrillation therapy, will be the first such device for CHF to be reviewed by the agency